699 Results for "

Compound-2

" in MedChemExpress (MCE) Product Catalog:
Products (699)

699 Results for "Compound-2" in MCE Product Catalog:

20
20 Publications Verification
Cat. No.: HY-100004
CAS No.: 1644060-37-6
Purity:  99.14%
Research Areas:  

Cancer

Fumarate hydratase-IN-1 (compound 2) is a cell-permeable fumarate hydratase inhibitor. Fumarate hydratase-IN-1 has antiproliferative activity against several cancer cell lines with a mean IC50 of 2.2 μM .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-111798A
CAS No.: 1092851-70-1
Purity:  99.03%
Research Areas:  

Cancer

Heme Oxygenase-1-IN-1 (Compound 2) hydrochloride is a heme oxygenase 1 (HO-1) inhibitor with an IC50 of 0.25 μM .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-111798
CAS No.: 1093058-52-6
Purity:  99.11%
Research Areas:  

Cancer

Heme Oxygenase-1-IN-1 (compound 2) is a potent heme oxygenase 1 (HO-1) inhibitor, with an IC50 of 0.25 μM. Heme Oxygenase-1-IN-1 can be used for cancer research .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-146195
CAS No.: 2470587-69-8
Purity:  95.85%
MAPK-IN-1 (Compound 2) is a MAPK signaling pathway inhibitor. MAPK-IN-1 exhibits AChE inhibitory activity with an IC50 of 23.84 μM. MAPK-IN-1 shows anti-neuroinflammatory and neuroprotective activity and can be used for Alzheimer's disease research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-139319
CAS No.: 227010-33-5
Purity:  99.88%
Target:  

Lactate Dehydrogenase

Research Areas:  

Cancer

LDHA-IN-3 (compound 2), as a selenobenzene compound, is a potent, noncompetitive lactate dehydrogenase (LDHA) inhibitor (IC50=145.2 nM). LDHA-IN-3 can be used for the research of cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12791
CAS No.: 1234708-04-3
Purity:  99.92%
hPGDS-IN-1 (Compound 2 ) is an hPGDS inhibitor with an IC50 of 12 nM (as measured by fluorescence polarization assay or EIA). hPGDS-IN-1 can be used in the research of allergic rhinitis and spinal cord neurons [2] .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N1881
CAS No.: 6665-67-4
4',5-Dihydroxyflavone (Compound 2c; Compound B3) is a type of flavonoid compound. 4',5-Dihydroxyflavone can inhibit various oxidases and its IC50 values for collagenase A (ColA) and α-glucosidase are less than 1 μM and 66 μM respectively; for soybean lipoxygenase-1 (LOX-1), its Ki value is 102.6 μM. 4',5-Dihydroxyflavone can be used in studies on anti-toxicity and anti-diabetes [2] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-136485
CAS No.: 1995893-58-7
Purity:  99.86%
Target:  

FLAP

Research Areas:  

Cancer

FEN1-IN-4 (Compound 2) is a human flap endonuclease-1 (hFEN1) inhibitor .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N12304
CAS No.: 21800-48-6
Xanthalin (compound 2) is a characteristic component isolated from Peucedanum ledebourielloides root .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-139323
CAS No.: 2205095-75-4
Purity:  99.92%
Research Areas:  

Inflammation/Immunology

TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b. TLR7/8-IN-1 can be used for the research of autoimmune disease .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-122723
CAS No.: 732973-87-4
Purity:  99.45%
Research Areas:  

Cancer

GOT1 inhibitor-1 (compound 2c), a tryptamine-based derivative, acts as a novel, potent and non-covalent inhibitor of glutamate oxaloacetate transaminase 1 (GOT1) with an IC50 of 8.2 uM. GOT1 plays an important role in energy metabolism and Reactive Oxygen Species (ROS) balance. GOT1 inhibitor-1 can be used for the research of pancreatic ductal adenocarcinoma (PDAC) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-130538
CAS No.: 6953-61-3
Purity:  99.72%
Target:  

HDAC

Research Areas:  

Cancer

1-Naphthohydroxamic acid (Compound 2) is a potent and selective HDAC8 inhibitor with an IC50 of 14 μM. 1-Naphthohydroxamic acid is more selectively for HDAC8 than class I HDAC1 and class II HDAC6 (IC50 >100 μM). 1-Naphthohydroxamic acid does not increase global histone H4 acetylation and also does not reduce total intracellular HDAC activity [2].1-Naphthohydroxamic acid can induce tubulin acetylation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-117602
CAS No.: 1229024-78-5
Purity:  99.90%
TLR7 agonist 3 (compound 2) is a TLR7 agonist and can be used for the stuy of cancers [2].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121834
CAS No.: 357618-26-9
Purity:  98.63%
Target:  

DNA/RNA Synthesis

Research Areas:  

Others

RNase L-IN-2 (compound 2) is an activtor of RNase L with EC50 value of 22 μM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-157573
CAS No.: 2245794-64-1
Purity:  97.0%
Target:  

Bacterial

Research Areas:  

Infection

N-Acetylmuramic acid-azide (Compound 2) is a derivative of N-acetylaminoacetic acid (NAM) in bacterial peptidoglycan. Incorporated into bacterial peptidoglycan during biosynthesis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N8600
CAS No.: 3440-24-2
7,8,3′,4′-Tetrahydroxyflavone (compound 2) is a potent xanthine oxidase (XOD) inhibitor with an IC50 value of 10.488 µM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111758
CAS No.: 2364367-27-9
Purity:  99.78%
Target:  

PROTACs Raf

Research Areas:  

Cancer

PROTAC B-Raf degrader 1 (compound 2) is a proteolysis targeting chimera (PROTAC) for the degradation of B-Raf based on Cereblon ligand with anti-cancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W011955
CAS No.: 35873-49-5
Target:  

Adenosine Receptor

Research Areas:  

Cardiovascular Disease

8-Cyclopentyl-1,3-dimethylxanthine (Compound 2a) is a selective adenosine A1 receptor antagonist with Kis of 10.9 nM and 1440 nM for A1 receptor and A2 receptor, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100734
CAS No.: 932749-62-7
Purity:  99.01%
Research Areas:  

Cancer

Histone Acetyltransferase Inhibitor II (compound 2c) is a potent, selective and cell permeable p300 histone acetyltransferase inhibitor, with an IC50 of 5 µM. Histone Acetyltransferase Inhibitor II shows anti-acetylase activity in mammalian cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-154965
CAS No.: 2920904-06-7
Purity:  99.62%
Synonyms: SIM0417; SARS-CoV-2-IN-41
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-41 (compound 2) is a potent SARS-CoV-2 3CL pro inhibitor with an IC50 value of 0.022 µM. SARS-CoV-2-IN-41 shows antiviral effect .
loading...
    loading...